Josefina Pérez‐Blanco

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder

Eduard Vieta, Núria Cruz, Javier Garcı́a-Campayo et al. · The International Journal of Neuropsychopharmacology · 2008 · 91 citations · Full text

[Validation study of the Center for Epidemiological Studies-Depression of a Spanish population of patients with affective disorders].

Joaquim Soler, Víctor Pérez, Dolors Puigdemont et al. · PubMed · 1997 · 71 citations

Psychological Co-morbidities, Psychiatric Disorders, Health Psychology +21

A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments

María J. Arranz, Alex Gonzalez-Rodriguez, Josefina Pérez‐Blanco et al. · Translational Psychiatry · 2019 · 49 citations · Full text

Predicting outcome of lithium added to antidepressants in resistant depression

Enric Álvarez, Víctor Pérez, Josefina Pérez‐Blanco et al. · Journal of Affective Disorders · 1997 · 30 citations

Resistant Depression, Psychiatry, Mood Symptom +12

Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial

Marina Garriga, Eva Solé, Ana González‐Pinto et al. · European Neuropsychopharmacology · 2017 · 21 citations

Psychiatry, Mood Symptom, Medicine +11